kabutan

3-D Matrix,Ltd.(7777) Summary

7777
TSE Growth
3-D Matrix,Ltd.
518
JPY
+2
(+0.39%)
Apr 28, 3:30 pm JST
3.25
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
513
Apr 28, 11:58 pm JST
Summary Chart Historical News Financial Result
PER
64.9
PBR
14.1
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
526 JPY 3.30 USD
Previous Close Apr 27
516 JPY 3.23 USD
High Apr 28, 9:46 am
535 JPY 3.35 USD
Low Apr 28, 1:32 pm
512 JPY 3.21 USD
Volume
2,382,600
Trading Value
1.25B JPY 7.82M USD
VWAP
522.47 JPY 3.28 USD
Minimum Trading Value
51,800 JPY 325 USD
Market Cap
0.07T JPY 0.42B USD
Number of Trades
1,946
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
2,327
1-Year High Sep 16, 2025
16,543
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 4,600 13,955,700 3033.85
Apr 17, 2026 0 12,930,400
Apr 10, 2026 0 13,197,200
Apr 3, 2026 0 13,915,400
Mar 27, 2026 0 12,804,200
Company Profile
3-D Matrix, Ltd. is a bioventure company that develops medical products by applying peptide technology. The company operates both domestically and internationally.
Sector
Precision Instruments
3-D Matrix, Ltd. conducts research and development, manufacturing, and sales of medical devices and pharmaceuticals based on self-assembling peptide technology, for which it has obtained an exclusive license from MIT. The company's main development pipeline includes absorbable local hemostatic agents for surgical applications, mucosal lifting agents, post-bleeding prevention materials, adhesion prevention materials, wound healing materials for tissue regeneration, alveolar bone reconstruction materials, and drug delivery systems (DDS) for nucleic acid therapeutics. 3-D Matrix has established direct sales systems in the United States, Japan, and Australia, while also conducting sales through partner companies in some regions.